Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice episode artwork

EPISODE · Dec 12, 2023 · 20 MIN

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

from Keeping Current CME

Did you know that patients with HER2-low metastatic breast cancer now have approved treatment options? Join for a discussion on trial data and testing. Credit available for this activity expires: 12/5/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/999024?ecd=bdc_podcast_libsyn_mscpedu

Episode metadata supplied by the publisher feed · Published Dec 12, 2023

Embed this episode

NOW PLAYING

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

0:00 20:34

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Keeping Current CME?

This episode is 20 minutes long.

When was this Keeping Current CME episode published?

This episode was published on December 12, 2023.

Can I download this Keeping Current CME episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!